We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ono Pharmaceutical Company Ltd (PK) | USOTC:OPHLY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 0.61% | 4.94 | 4.87 | 5.03 | 4.94 | 4.84 | 4.84 | 45,929 | 21:01:52 |
As filed with the Securities and Exchange Commission on April 25, 2017
|
Registration No. 333-214131
|
Francis Fitzherbert-Brockholes, Esq.
White & Case LLP
5 Old Broad Street
London EC2N 1DW
United Kingdom
+(44) 20 7532-1400
|
It is proposed that this filing become effective under Rule 466:
|
o
immediately upon filing.
o
on (Date) at (Time).
|
Title of each class
of Securities to be registered
|
Amount to be registered
|
Proposed
maximum aggregate price per unit
(1)
|
Proposed
maximum aggregate offering price
(2)
|
Amount of registration fee
(3)
|
American Depositary Shares, each representing one third of one share of common stock of Ono Pharmaceutical Co Ltd
|
10,000,000 American Depositary Shares
|
$0.05
|
$500,000
|
$57.95
|
1
|
For the purpose of this table only the term "unit" is defined as one American Depositary Share.
|
2
|
Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Shares.
|
3
|
Previously paid.
|
(i)
|
The amount of deposited securities represented by one American Depositary Share (“ADS”)
|
Face of Receipt – upper right corner
|
||
(ii) |
The procedure for voting the deposited securities
|
Reverse of Receipt – Articles 11 and 13
|
||
(iii)
|
The procedure for collecting and distributing dividends
|
Reverse of Receipt – Articles 12 and 18
|
||
(iv) |
The procedures for transmitting notices, reports and proxy soliciting material
|
Reverse of Receipt – Articles 11 and 15
|
||
(v) | The sale or exercise of rights | Reverse of Receipt – Articles 12 and 13 | ||
(vi) | The deposit or sale of securities resulting from dividends, splits or plans of reorganization | Reverse of Receipt – Articles 12 and 15 | ||
(vii) | Amendment, extension or termination of the deposit arrangements | Reverse of Receipt – Articles 17 and 18 (no provision for extension) | ||
(viii) | The rights of holders of Receipts to inspect the books of the depositary and the list of holders of Receipts | Face of Receipt – Article 3 | ||
(ix) | Restrictions upon the right to transfer or withdraw the underlying securities |
Face of Receipt – Article 1, 2, 4 and 6;
Reverse of Receipt – Articles 14, 15 and 18
|
||
(x) | Limitation on the depositary’s liability |
Face of Receipt – Article 1, 2, 4 and 7;
Reverse of Receipt – Articles 11, 12, 14, 15, 16, 18 and 21
|
||
3. |
Fees and charges that a holder of Receipts may have to pay, either directly or indirectly
|
Reverse of Receipt – Article 19
|
Required Information
|
Location in Form of Receipt Filed Herewith as Prospectus
|
|||
(b)
|
Statement that as of the date of the establishment of the program for issuance of Receipts by the Depositary, the Depositary has a good faith belief (after limited investigation), that the issuer of the Deposited Securities publishes information in English required to maintain the exemption from registration under Rules 12g3-2(b) under the Securities Exchange Act of 1934 on its internet website or through an electronic information delivery system generally available to the public in its primary trading market.
|
Face of Receipt – Article 8
|
(a)
|
Copy of Agreement – The Agreement between Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and all holders and beneficial owners from time to time of ADSs registered hereunder is contained in the form of the American Depositary Receipt itself, constituting the prospectus filed as part of the registration statement. — Filed herewith as Exhibit (a).
|
(b)
|
Any other agreement to which the Depositary is a party relating to the issuance of the ADSs registered hereunder or the custody of the deposited securities represented thereby. — Not applicable.
|
(c)
|
Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — Not applicable.
|
(d)
|
Opinion of White & Case LLP, counsel to the Depositary, as to the legality of the securities to be registered. — Previously filed (Form F-6, File No. 333-214131, October 17, 2016) as Exhibit (d).
|
(a)
|
The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities; and (2) made generally available to the holders of the underlying securities by the issuer.
|
(b)
|
If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADS thirty (30) days before any change in the fee schedule.
|
Legal entity created by the agreement for the issuance of American Depositary Receipts evidencing American Depositary Shares for shares of the foreign private issuer whose name is set forth on the facing page of this Registration Statement on Form F-6.
DEUTSCHE BANK TRUST COMPANY AMERICAS, as Depositary
|
|||||
By:
|
/s/ Michael Fitzpatrick
|
||||
Name: Michael Fitzpatrick
Title: Vice President
|
|||||
By:
|
/s/ Michael Curran
|
||||
Name: Michael Curran
Title: Vice President
|
Exhibit
|
Document
|
(a)
|
Form of American Depositary Receipt
|
|
|
1 Year Ono Pharmaceutical (PK) Chart |
1 Month Ono Pharmaceutical (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions